Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(38%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_2
1
13%
Ph phase_3
1
13%
Ph phase_4
5
63%
Ph not_applicable
1
13%

Phase Distribution

0

Early Stage

1

Mid Stage

6

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
1(12.5%)
Phase 4Post-market surveillance
5(62.5%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(4)
Completed(2)
Other(2)

Detailed Status

Recruiting3
Completed2
unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (12.5%)
Phase 31 (12.5%)
Phase 45 (62.5%)
N/A1 (12.5%)

Trials by Status

completed225%
unknown225%
not_yet_recruiting113%
recruiting338%

Recent Activity

3 active trials
Showing 5 of 8
recruitingphase_4

Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention

NCT07243080
not_yet_recruitingphase_3

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

NCT06580223
recruitingphase_2

HIP Fracture Oral ThromboPROphylaxis (Hip PRO Pilot)

NCT05775965
recruitingnot_applicable

Low-dose NOAC Versus GDMT After LAAO

NCT05960721
completedphase_4

Combined Topical Tranexamic Acid With Floseal® in Total Knee Arthroplasty

NCT03328832
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07243080Phase 4

Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention

Recruiting
NCT06580223Phase 3

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Not Yet Recruiting
NCT05775965Phase 2

HIP Fracture Oral ThromboPROphylaxis (Hip PRO Pilot)

Recruiting
NCT05960721Not Applicable

Low-dose NOAC Versus GDMT After LAAO

Recruiting
NCT03328832Phase 4

Combined Topical Tranexamic Acid With Floseal® in Total Knee Arthroplasty

Completed
NCT04256525Phase 4

Prophylactic Anticoagulation for Catheter-related Thrombosis

Unknown
NCT02458729Phase 4

The Blood Saving Effect of Tranexamic Acid in Total Knee Arthroplasty With Rivaroxaban as Thromboprophylaxis

Completed
NCT02453802Phase 4

Comparison of Topical and Infusion Tranexamic Acid After Total Knee Arthroplasty

Unknown

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8